Verge Medical Inc.

Verge Medical (formerly Ostial Corporation) is a privately held medical technology company specializing in vascular intervention devices for coronary and peripheral markets. The company's flagship product is the FLASH™ (Flared Lesion Angioplasty System with Hemodynamic optimization) Ostial Angioplasty System, a novel dual-balloon device designed for aorto-ostial stenting in both coronary and peripheral indications. The FLASH system employs patented dual-balloon technology: a non-compliant distal balloon for system anchoring and a compliant, low-pressure proximal balloon that conforms the stent to the ostial wall, achieving TRUE 360° flared apposition. Clinical data demonstrates 97% complete stent apposition rates and restenosis below 9% at 6 months. Over 25,000 FLASH systems have been sold across more than 300 US hospitals. In addition to the FLASH system, Verge Medical recently acquired the RoVo™ System featuring Temporary Occlusion Embolectomy (TOE) technology for peripheral embolic protection and the Wavella™ technology from Crossfire Medical to expand its interventional portfolio. The company operates in both inpatient and office-based settings. Products are indicated for use by trained interventional cardiologists and vascular specialists. The company maintains regulatory clearance for its devices and emphasizes physician training and support. Verge Medical is backed by institutional investors including Delos Capital and AMED Ventures.